4.7 Article

Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells

Journal

SCIENTIFIC REPORTS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-019-46359-6

Keywords

-

Funding

  1. National Institutes of Health [R01HL096987]
  2. Ko Family Foundation
  3. Oxnard Foundation
  4. UCI Stem Cell Training Grant from the California Institute of Regenerative Medicine

Ask authors/readers for more resources

The signaling mechanisms controlling somatic cell reprogramming are not fully understood. In this study, we report a novel role for mitochondrial Akt1 signaling that enhanced somatic cell reprogramming efficiency. The role of mitochondrial Akt1 in somatic cell reprogramming was investigated by transducing fibroblasts with the four reprogramming factors (Oct4, Sox2, Klf4, c-Myc) in conjunction with Mito-Akt1, Mito-dnAkt1, or control virus. Mito-Akt1 enhanced reprogramming efficiency whereas Mito-dnAkt1 inhibited reprogramming. The resulting iPSCs formed embryoid bodies in vitro and teratomas in vivo. Moreover, Oct4 and Nanog promoter methylation was reduced in the iPSCs generated in the presence of Mito-Akt1. Akt1 was activated and translocated into mitochondria after growth factor stimulation in embryonic stem cells (ESCs). To study the effect of mitochondrial Akt in ESCs, a mitochondria-targeting constitutively active Akt1 (Mito-Akt1) was expressed in ESCs. Gene expression profiling showed upregulation of genes that promote stem cell proliferation and survival and down-regulation of genes that promote differentiation. Analysis of cellular respiration indicated similar metabolic profile in the resulting iPSCs and ESCs, suggesting comparable bioenergetics. These findings showed that activation of mitochondrial Akt1 signaling was required during somatic cell reprogramming.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Hepatic proteomic analysis revealed altered metabolic pathways in insulin resistant Akt1 +/-/Akt2 -/- mice

Brian A. Pedersen, Weiwen Wang, Jared F. Taylor, Omar S. Khattab, Yu-Han Chen, Robert A. Edwards, Puya G. Yazdi, Ping H. Wang

METABOLISM-CLINICAL AND EXPERIMENTAL (2015)

Article Medicine, Research & Experimental

Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1

Yang Cao, Lingyi Tang, Kang Du, Kitt Paraiso, Qiushi Sun, Zhengxia Liu, Xiaolong Ye, Yuan Fang, Fang Yuan, Hank Chen, Yumay Chen, Xiaorong Wang, Clinton Yu, Ira L. Blitz, Ping H. Wang, Lan Huang, Haibo Cheng, Xiang Lu, Ken W. Y. Cho, Marcus Seldin, Zhuyuan Fang, Qin Yang

Summary: LSD1 regulates mitochondrial function and hepatokine production by modulating histone methylation and NAD+ synthesis. Deletion of LSD1 in mice reduces mitochondrial function in the liver but protects against diet-induced hepatic steatosis and glucose intolerance, partially due to the induction of the hepatokine FGF21.

JCI INSIGHT (2021)

No Data Available